According to the latest research by Future Market Insights, the Faecal Calprotectin Testing Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.
With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientists’ will to find new ways to treat diseases in the forecast period to the global market.
What is Driving Demand for Faecal Calprotectin Testing Market?
Crohn’s disease and ulcerative colitis come under the gambit of inflammatory bowel syndromes. Calprotectin is a serum which is present at site of any kind of inflammation; hence it is also called as an inflammatory marker or biomarker. Making IBS a major driver in this testing market. Changes in calprotectin levels of a faecal sample can play a major role in identifying the bowel syndromes which cause inflammation, making it a major driver of the market.
The capability of calprotectin to be able differentiate between irritable bowel syndrome and inflammatory bowel syndrome makes is a most impactful driver of this market. This uniqueness of calprotectin makes it swift in detection and treatment of bowel related diseases.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14039
Constant alteration in the diet of individuals raise the risk of IBS and increase an individual’s susceptibility towards it. A more detailed study to understand this relation will definitely assist in making necessary changes in its testing and act as a driving factor.
Prediction of post-operative recurrence of Crohn’s disease –
As published by researchers in the Digestive and Liver Disease Journal in May 2020, faecal calprotectin has a potential application in detecting the reoccurrence of Crohn’s disease.
As established earlier, Calprotectin presents itself at the site of any kind of inflammation and is therefore known as an inflammatory biomarker. This recent study shows that this serum can also act as predictive indicator in some cases. Variation in its levels in the patients with history of Crohn’s disease proved to be an indicator of recurrence of the disease. This and many future findings will help in making individuals actively do the testing and hence give a boost to the market.
U.S. and Canada Faecal Calprotectin Testing Market –
According to Centre for Disease Control, colorectal cancer ranks 4th among the top 10 cancer prevalence in US. Investments and government support in conducting research in various verticals will definitely attract more attention to the faecal calprotectin market.
Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.
Europe Faecal Calprotectin Testing Market –
European region seems to be at the front for faecal calprotectin testing. Looking at the recent developments, European authorities tend to focus on encouraging exploration of new applications in any section of healthcare sector. A very peculiar study published in the Scandinavian Journal of Gastroenterology, explored the application of calprotectin faecal testing in diagnosis of colorectal cancer, as abdominal complaints are quite common in colorectal cancer patients.
Another interesting development which makes Europe a leading market in this market, is a study conducted with an attempt establish a connection between dermatological complications and faecal calprotectin. According to this Journal of Clinical and Experimental Dermatology published article, skin lesions are very common occurrence in inflammatory bowel syndrome (IBS). Given the sensitivity of the serum calprotectin towards inflammation, proper targeted testing done in this direction will definitely give a boost to this market.
Who are the key manufacturing and supplying companies in Faecal Calprotectin Testing Market?
Key Players:
- ALPCO
- Alpha Laboratories
- bioMérieux SA
- Canvax Biotech
- DRG Instruments GmbH
- Promega Corporation
- Svar Lifescience (CALPRO)
- Arbor Assays
- Werfen
- BUEHLMANN
For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14039
Why Future Market Insights?
- Comprehensive analysis on evolving purchase pattern across different geographies
- Detailed insights of market segments and sub-segments for historical as well as forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com